Particle.news
Heart Disease Hypertension Risk Factors Cardiovascular Disease Risk Assessment Cholesterol Management Heart Attack Heart Failure Coronary Artery Disease Blood Pressure Cardiovascular Diseases Medications Research Diseases Disease Prevention Atherosclerosis Blood Vessels Blood Pressure Management Heart Attacks Surgical Trials Myocardial Infarction Complications Stroke Aortic Valve Blood Thinners Cardiovascular Events Monitoring Devices Clinical Guidelines Atrial Fibrillation Cardiac Rehabilitation Vascular Aging Patient Outcomes Emergency Care Cardiovascular Risk Patient Management Medical Facilities Clinical Trials Risks Health Assessments Heart Attack Risk Heart Disease Prevention Obesity Risk Reduction Inflammation Research Studies Mortality Rates Cardiometabolic Health Biomarkers Heart Risks Endothelial Function Heart Conditions Cholesterol Disorders Cholesterol Ischemic Heart Disease Stroke Treatment Wearable Technology Patient Care
The finding strengthens the case for prescribing GLP-1 drugs based on cardiovascular risk rather than weight alone.
